Sionna Therapeutics share price logo

Sionna Therapeutics Share Price

NASDAQ: SION

Large Cap

$38.00

+0.48

(+1.28%)

as on

Sionna Therapeutics Stock Performance

as on October 31, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $37.15
    $38.4
    downward going graph

    2.24%

    Downside

    1.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.26
    $43.2
    downward going graph

    80.91%

    Downside

    13.67%

    Upside

    downward going graph

Sionna Therapeutics share price movements today

Previous Close
$37.52
Open
$37.15
Volume
259.5K
Day's Low - High
$37.15 - $38.4
52 Week Low - High
$7.26 - $43.2

Sionna Therapeutics Historical Returns

1 Month Return
+ 27.58 %
3 Month Return
+ 111.38 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Sionna Therapeutics Stock Fundamentals & Key Indicators

Check Sionna Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$769.0M

EPS (TTM)

-2.34

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Sionna Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sionna Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Sionna Therapeutics image
Sionna Therapeutics
NA$769.0MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$62.4B291.63%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$36.4BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$108.3B100.24%30.0231.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$69.4B20.12%15.732.13%

Sionna Therapeutics Stock’s Investor Sentiment and Interest

Search interest for Sionna Therapeutics Stock has increased by 350% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:350% versus previous 30 day period

Sionna Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
0
-
-
-
0
Operating Income
-12
-13
-11
-27
-18
-19
-21
EBITDA
-12
-12
-8
-
-17
-19
-21
Interest Expense
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-11
-11
-8
-25
-15
-16
-18
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-11
-11
-8
-25
-15
-16
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Sionna Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
Gross Profit
-
-
-
Operating Income
-41
-50
-70
EBITDA
-41
-49
-69
Interest Expense
-
-
-
Depreciation
0
0
0
Income Before Tax
-40
-47
-61
Income Tax Expense
-
-
-
Net Income
-40
-47
-61
Net Profit Margin
0.00%
0.00%
0.00%

Sionna Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-11
-8
-25
-15
-16
-18
Operating Cash Flow
-13
-10
-17
-11
-16
-18
Investing Cash Flow
-123
-28
-
15
-141
-23
Financing Cash Flow
181
0
0
-1
202
0
Change in Cash
44
-38
-8
2
44
-41

Sionna Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Net Income
-47
-61
Operating Cash Flow
-43
-52
Investing Cash Flow
27
-126
Financing Cash Flow
0
178
Change in Cash
-16
0

Insights on Sionna Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SION stock has moved up by 27.6%

About Sionna Therapeutics

Sionna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on researching and developing novel medicines for cystic fibrosis. It is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in nucleotide-binding domain 1 (NBD1). It is conducting ongoing Phase I trials of its two highly potent NBD1 stabilizers, SION-719 and SION-451, evaluating the safety, tolerability and pharmacokinetic (PK) profile of single and multiple ascending doses in healthy subjects. It is also developing a portfolio of cystic fibrosis transmembrane conductance regulator (CFTR) modulators designed to work synergistically with its NBD1 stabilizers to improve CFTR function. Its portfolio also includes Galicaftor (SION-2222) and SION-2851, which are TMD1-directed CFTR correctors; SION-109, an ICL4-directed CFTR corrector, and Navocaftor (SION-3067), is a clinical-stage potentiator of CFTR gating activity.
OrganisationSionna Therapeutics
Headquarters21 Hickory Drive, Waltham, MA, United States, 02451
CEOMr. Michael Cloonan M.B.A.
E-voting on sharesClick here to vote

Key Management of Sionna Therapeutics

Name

Title

Dr. Greg Hurlbut Ph.D.

Co-Founder & Senior VP of Discovery Research

Dr. Mark Munson Ph.D.

Co-founder & Senior VP of Medicinal Chemistry

Ms. Meghan Bagshaw

Vice President of Programs, Portfolio & Operations

Ms. Jennifer Fitzpatrick J.D.

Chief Legal Officer

Mr. Michael Cloonan M.B.A.

President, CEO & Director

Ms. Elena H. Ridloff C.F.A.

Chief Financial Officer

Ms. Vanya Sagar

Chief People Officer

Ms. Mara Furlow M.S.

Senior Vice President of Global Regulatory Affairs & Quality

Dr. Charlotte McKee M.D.

Chief Medical Officer

Mr. Andy Chu

Vice President of Information & Technology

FAQs

What is Sionna Therapeutics share price today?

Sionna Therapeutics share price today is $38 as on at the close of the market. Sionna Therapeutics share today touched a day high of $38.4 and a low of $37.15.

What is the 52 week high and 52 week low for Sionna Therapeutics share?

Sionna Therapeutics share touched a 52 week high of $43.2 on and a 52 week low of $7.26 on . Sionna Therapeutics stock price today i.e. is closed at $38,which is 12.03% down from its 52 week high and 423.78% up from its 52 week low.

What is Sionna Therapeutics's market capitalisation today?

Sionna Therapeutics market capitalisation is $0.00T as on .

How to invest in Sionna Therapeutics Stock (SION) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sionna Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sionna Therapeutics Shares that will get you 0.0395 shares as per Sionna Therapeutics share price of $38 per share as on October 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sionna Therapeutics Stock (SION) from India?

Indian investors can start investing in Sionna Therapeutics (SION) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Sionna Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Sionna Therapeutics share’s latest price of $38 as on October 31, 2025 at 1:29 am IST, you will get 0.2632 shares of Sionna Therapeutics. Learn more about fractional shares .